Developing BioPesticides for the future
Co-operation agreement between Agrolab and BioScience Solutions
Middelfart, 01 March 2018 – Agrolab and BioScience Solutions announces the cooperation regarding consultancy for development of bio-pesticides.
Harry Teicher, owner and founder of BioScience Solutions has long experience of biopesticides and the challenges that lies with testing and developing these natural substances.
Agrolab has long experience of trial conducting in Northern Europe and the data requirements for registration of plant protection products.
“With this joint venture and co-operation, we are able to take the support of our clients with the development of bio-pesticides to a new level” said Martin Gejl, owner and CEO of Agrolab. “This way we can utilize the extensive experience of bio-pesticide development from Harry Teicher and the huge field trial experience from Agrolab and in combination achieve a much better success rate of trials and development of biopesticides”
“AgChem companies are expanding their biopesticide R&D and portfolios in response to stricter pesticide regulatory requirements, consumer awareness regarding hazards caused by chemical pesticides, and the growing commercial success of biology-based crop protection strategies” added Harry Teicher.
“For the design of biopesticide efficacy trials and the successful introduction of these products, we can advise our clients on critical decision-making parameters for the strategic viability of the tested product, including biopesticide mode-of-action and application timing as well as evaluation parameters.
Biopesticides (microbial pesticides, bio-derived chemicals and plant-incorporated protectants) introduce unique and complex modes of action and may be used in plant production on an equal footing with chemical pesticides
Even though biopesticides have been commercially used for over 60 years, they have generally been evaluated and registered following the model for the registration of conventional pesticides, and laws and policies regulating their use vary from country to country. Submission procedures have often been lengthy, and the high cost of registration has limited the commercialization of new and safer biopesticidal products, particularly in the EU.
The lengthy submission procedures combined with the complex and difficult nature of biopesticides makes it even more important to have the right strategy and plan from the start when it comes to trials and development of these products. Trials are costly and the success needs to be maximized as early as possible in the process to achieve a registration at a reasonable cost.